Theralase Technologies Inc.

OTCPK:TLTF.F Stock Report

Market Cap: US$54.6m

Theralase Technologies Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:TLTF.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
20 May 26BuyUS$1,921Kristina HacheyIndividual11,000US$0.17
20 May 26BuyUS$4,366Roger Dumoulin-WhiteIndividual25,000US$0.17
20 May 26BuyUS$1,921Arkady MandelIndividual11,000US$0.17
20 May 26BuyUS$1,921Matthew PerratonIndividual11,000US$0.17
20 May 26BuyUS$12,481Kaouthar LbiatiIndividual65,973US$0.19
20 May 26BuyUS$3,650Randy BruderIndividual20,900US$0.17
10 Apr 26BuyUS$128,616Roger Dumoulin-WhiteIndividual684,000US$0.19
10 Apr 26BuyUS$8,875Kristina HacheyIndividual47,200US$0.19
10 Apr 26BuyUS$17,675Arkady MandelIndividual94,000US$0.19
10 Apr 26BuyUS$8,006Matthew PerratonIndividual53,700US$0.19
10 Apr 26BuyUS$11,658Kristina HacheyIndividual62,000US$0.19
10 Apr 26BuyUS$1,880Matthew PerratonIndividual10,000US$0.19
28 Jul 25BuyUS$18,954Kristina HacheyIndividual130,000US$0.15

Insider Trading Volume

Insider Buying: TLTF.F insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of TLTF.F?
Owner TypeNumber of SharesOwnership Percentage
Institutions428,5710.145%
Individual Insiders19,220,7506.5%
General Public276,021,99793.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 16.5%.

Top Shareholders

Top 8 shareholders own 6.65% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
4.31%
Roger Dumoulin-White
12,742,997US$2.4m5.89%no data
1.11%
Kristina Hachey
3,277,045US$604.8k2.28%no data
0.64%
Randy Bruder
1,888,978US$348.6k1.95%no data
0.17%
Arkady Mandel
493,889US$91.1k27%no data
0.14%
Parkview Financial LLC
428,571US$79.1k0%no data
0.14%
Guy Anderson
408,334US$75.4k0%no data
0.083%
Kaouthar Lbiati
246,507US$45.5k36.5%no data
0.055%
Matthew Perraton
163,000US$30.1k14.8%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/23 22:44
End of Day Share Price 2026/07/23 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Theralase Technologies Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Andre UddinResearch Capital Corporation